Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions
Received 11 January 2005; received in revised form 4 February 2005; accepted 6 February 2005.
Abstract
A wide range of methods is now available for assessing the nature and characteristics of drug injecting populations, and for evaluating the effectiveness of interventions developed to reduce injecting related harms. The public health surveillance tasks in relation to injecting drug use populations and associated health problems are the same, in principle, as for the surveillance of other health problems. These are: to describe the patterns of the condition, the nature of the problem and the environment (context) in which it occurs; to determine the scale of interventions needed and estimated coverage required, to forecast future health care needs; to mobilise resources and target prevention; and to evaluate interventions. Countries vary in their existing levels of information as well as resources for surveillance systems, research and evaluation. We propose three levels of assessment: basic assessment, which is suitable in situations of low awareness and information, routine surveillance, and enhanced surveillance, which requires more complex research and/or analyses of data collected from routine surveillance.
aDepartment of Primary Care and Social Medicine, The Centre for Research on Drugs and Health Behaviour, Imperial College, The Reynolds Building, St Dunstan's Road, London W6 8RP, UK
bInternational Harm Reduction Association, PO Box 818, North Melbourne 3051, Melbourne, Vic., Australia
cOwaldo Cruz Foundation, Av. Brasil, 4365, Biblioteca de Manguinhos #229, 21045-900 Rio de Janeiro, Brazil
dFamily Health International, Asia Regional Office, Arwan Building, 8th Floor, 1339 Pracharat 1 Road, Bangsue, Bangkok 10800, Thailand